1. Home
  2. CING vs VVOS Comparison

CING vs VVOS Comparison

Compare CING & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • VVOS
  • Stock Information
  • Founded
  • CING 2012
  • VVOS 2016
  • Country
  • CING United States
  • VVOS United States
  • Employees
  • CING N/A
  • VVOS N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • VVOS Medical Specialities
  • Sector
  • CING Health Care
  • VVOS Health Care
  • Exchange
  • CING Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • CING 16.2M
  • VVOS 14.8M
  • IPO Year
  • CING 2021
  • VVOS 2020
  • Fundamental
  • Price
  • CING $4.36
  • VVOS $2.23
  • Analyst Decision
  • CING Strong Buy
  • VVOS Strong Buy
  • Analyst Count
  • CING 4
  • VVOS 2
  • Target Price
  • CING $30.67
  • VVOS $6.10
  • AVG Volume (30 Days)
  • CING 250.6K
  • VVOS 133.6K
  • Earning Date
  • CING 05-08-2025
  • VVOS 05-15-2025
  • Dividend Yield
  • CING N/A
  • VVOS N/A
  • EPS Growth
  • CING N/A
  • VVOS N/A
  • EPS
  • CING N/A
  • VVOS N/A
  • Revenue
  • CING N/A
  • VVOS $14,628,000.00
  • Revenue This Year
  • CING N/A
  • VVOS $17.40
  • Revenue Next Year
  • CING N/A
  • VVOS $10.78
  • P/E Ratio
  • CING N/A
  • VVOS N/A
  • Revenue Growth
  • CING N/A
  • VVOS 9.47
  • 52 Week Low
  • CING $1.80
  • VVOS $1.97
  • 52 Week High
  • CING $20.83
  • VVOS $6.28
  • Technical
  • Relative Strength Index (RSI)
  • CING 61.94
  • VVOS 40.40
  • Support Level
  • CING $3.81
  • VVOS $2.22
  • Resistance Level
  • CING $4.09
  • VVOS $2.49
  • Average True Range (ATR)
  • CING 0.26
  • VVOS 0.22
  • MACD
  • CING 0.07
  • VVOS -0.01
  • Stochastic Oscillator
  • CING 96.43
  • VVOS 43.86

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: